1025700-49-5 Usage
General Description
5-Bromo-4-isopropylthiazol-2-amine is a chemical compound with the molecular formula C8H10BrN2S. It is a thiazole derivative, containing a thiazole ring with a bromine substituent at the 5-position and an isopropyl group attached to the 4-position. 5-broMo-4-isopropylthiazol-2-aMine is used in organic synthesis and medicinal chemistry as a building block for the preparation of various pharmaceuticals, agrochemicals, and other fine chemicals. It may also possess biological activities and is a potential drug candidate for further research and development. Additionally, it can be used as a precursor in the synthesis of novel compounds for various applications in the field of chemistry and pharmaceutical science.
Check Digit Verification of cas no
The CAS Registry Mumber 1025700-49-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,5,7,0 and 0 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1025700-49:
(9*1)+(8*0)+(7*2)+(6*5)+(5*7)+(4*0)+(3*0)+(2*4)+(1*9)=105
105 % 10 = 5
So 1025700-49-5 is a valid CAS Registry Number.
InChI:InChI=1S/C6H9BrN2S/c1-3(2)4-5(7)10-6(8)9-4/h3H,1-2H3,(H2,8,9)
1025700-49-5Relevant articles and documents
THIAZOLE AND OXAZOLE-SUBSTITUTED ARYLAMIDES AS P2X3 AND P2X2/3 ANTAGONISTS
-
Page/Page column 38, (2012/02/03)
Compounds of the formula I: or a pharmaceutically acceptable salt thereof, wherein, R1 is a group of formula A or formula B, and X, R2, R3, R4, R5, R6, Ra and Rb are as defined herein. Also provided are methods of using the compounds for treating diseases mediated by a P2X3 and/or a P2X2/3 receptor antagonist and methods of making the subject compounds.
THIAZOLE AND OXAZOLE-SUBSTITUTED ARYLAMIDES
-
Page/Page column 62; 63, (2008/12/05)
Compounds of the formula (I) or a pharmaceutically acceptable salt thereof, wherein: R1 is a group of formula A or formula B; and X, R2, R3, R4, R5, R6, Ra and Rb are as defined herein. Also provided are methods of using the compounds for treating diseases mediated by a P2X3 and/or a P2X2/3 receptor antagonist and methods of making the subject compounds.
